Literature DB >> 18806823

CSR1 induces cell death through inactivation of CPSF3.

Z-H Zhu1, Y P Yu, Y-K Shi, J B Nelson, J-H Luo.   

Abstract

CSR1 (cellular stress response 1), a newly characterized tumor-suppressor gene, undergoes hypermethylation in over 30% of prostate cancers. Re-expression of CSR1 inhibits cell growth and induces cell death, but the mechanism by which CSR1 suppresses tumor growth is not clear. In this study, we screened a prostate cDNA library using a yeast two-hybrid system and found that the cleavage and polyadenylation-specific factor 3 (CPSF3), an essential component for converting heteronuclear RNA to mRNA, binds with high affinity to the CSR1 C terminus. Further analyses determined that the binding motifs for CPSF3 are located between amino acids 440 and 543. The interaction between CSR1 and CPSF3 induced CPSF3 translocation from the nucleus to the cytoplasm, resulting in inhibition of polyadenylation both in vitro and in vivo. Downregulation of CPSF3 using small interfering RNA induced cell death in a manner similar to CSR1 expression. A CSR1 mutant unable to bind to CPSF3 did not alter CPSF3 subcellular distribution, did not inhibit its polyadenylation activity and did not induce cell death. In summary, CSR1 appears to induce cell death through a novel mechanism by hijacking a critical RNA processing enzyme.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18806823      PMCID: PMC2918272          DOI: 10.1038/onc.2008.359

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  18 in total

1.  Evidence that polyadenylation factor CPSF-73 is the mRNA 3' processing endonuclease.

Authors:  Kevin Ryan; Olga Calvo; James L Manley
Journal:  RNA       Date:  2004-04       Impact factor: 4.942

2.  A new method to detect apoptosis in paraffin sections: in situ end-labeling of fragmented DNA.

Authors:  J H Wijsman; R R Jonker; R Keijzer; C J van de Velde; C J Cornelisse; J H van Dierendonck
Journal:  J Histochem Cytochem       Date:  1993-01       Impact factor: 2.479

3.  CSR, a scavenger receptor-like protein with a protective role against cellular damage causedby UV irradiation and oxidative stress.

Authors:  H J Han; T Tokino; Y Nakamura
Journal:  Hum Mol Genet       Date:  1998-06       Impact factor: 6.150

Review 4.  Molecular markers for prostate cancer metastasis. Developing diagnostic methods for predicting the aggressiveness of prostate cancer.

Authors:  J T Isaacs
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

5.  Unchanged frequency of loss of heterozygosity and size of the deleted region at 8p21-23 during metastasis of lung cancer.

Authors:  F Kurimoto; A Gemma; Y Hosoya; M Seike; K Takenaka; K Uematsu; A Yoshimura; M Shibuya; S Kudoh
Journal:  Int J Mol Med       Date:  2001-07       Impact factor: 4.101

6.  Allelic losses at chromosome 8p21-23 are early and frequent events in the pathogenesis of lung cancer.

Authors:  I I Wistuba; C Behrens; A K Virmani; S Milchgrub; S Syed; S Lam; B Mackay; J D Minna; A F Gazdar
Journal:  Cancer Res       Date:  1999-04-15       Impact factor: 12.701

7.  Deletion mapping of the short arm of chromosome 8 in non-small cell lung carcinoma.

Authors:  H Ohata; M Emi; Y Fujiwara; K Higashino; K Nakagawa; R Futagami; E Tsuchiya; Y Nakamura
Journal:  Genes Chromosomes Cancer       Date:  1993-06       Impact factor: 5.006

8.  Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy.

Authors:  Yan Ping Yu; Douglas Landsittel; Ling Jing; Joel Nelson; Baoguo Ren; Lijun Liu; Courtney McDonald; Ryan Thomas; Rajiv Dhir; Sydney Finkelstein; George Michalopoulos; Michael Becich; Jian-Hua Luo
Journal:  J Clin Oncol       Date:  2004-07-15       Impact factor: 44.544

9.  Cancer statistics, 2008.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Taylor Murray; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2008-02-20       Impact factor: 508.702

10.  Prognostic implications of loss of heterozygosity at 8p21 and 9p21 in head and neck squamous cell carcinoma.

Authors:  Steven W Coon; Adnan T Savera; Richard J Zarbo; Michael S Benninger; Gary A Chase; Benjamin A Rybicki; Daniel L Van Dyke
Journal:  Int J Cancer       Date:  2004-08-20       Impact factor: 7.396

View more
  21 in total

1.  The hinge domain of the cleavage stimulation factor protein CstF-64 is essential for CstF-77 interaction, nuclear localization, and polyadenylation.

Authors:  J Andrew Hockert; Hsiang-Jui Yeh; Clinton C MacDonald
Journal:  J Biol Chem       Date:  2009-11-03       Impact factor: 5.157

2.  The DNA replication licensing factor miniature chromosome maintenance 7 is essential for RNA splicing of epidermal growth factor receptor, c-Met, and platelet-derived growth factor receptor.

Authors:  Zhang-Hui Chen; Yan P Yu; George Michalopoulos; Joel Nelson; Jian-Hua Luo
Journal:  J Biol Chem       Date:  2014-11-25       Impact factor: 5.157

3.  Integrin α7 binds tissue inhibitor of metalloproteinase 3 to suppress growth of prostate cancer cells.

Authors:  Lang-Zhu Tan; Yang Song; Joel Nelson; Yan P Yu; Jian-Hua Luo
Journal:  Am J Pathol       Date:  2013-07-02       Impact factor: 4.307

4.  Interaction of CSR1 with XIAP reverses inhibition of caspases and accelerates cell death.

Authors:  Zhong-Liang Zheng; Lang-Zhu Tan; Yan P Yu; George Michalopoulos; Jian-Hua Luo
Journal:  Am J Pathol       Date:  2012-06-08       Impact factor: 4.307

5.  Interaction of MCM7 and RACK1 for activation of MCM7 and cell growth.

Authors:  Xi-Yue Zhang; Lang-Zhu Tang; Bao-Guo Ren; Yan P Yu; Joel Nelson; George Michalopoulos; Jian-Hua Luo
Journal:  Am J Pathol       Date:  2013-01-11       Impact factor: 4.307

Review 6.  Scavenger receptor-A (CD204): a two-edged sword in health and disease.

Authors:  Jim L Kelley; Tammy R Ozment; Chuanfu Li; John B Schweitzer; David L Williams
Journal:  Crit Rev Immunol       Date:  2014       Impact factor: 2.214

7.  Oncogenic Activity of miR-650 in Prostate Cancer Is Mediated by Suppression of CSR1 Expression.

Authors:  Ze-Hua Zuo; Yan P Yu; Ying Ding; Silvia Liu; Amantha Martin; George Tseng; Jian-Hua Luo
Journal:  Am J Pathol       Date:  2015-05-05       Impact factor: 4.307

8.  Alterations in polyadenylation and its implications for endocrine disease.

Authors:  Anders Rehfeld; Mireya Plass; Anders Krogh; Lennart Friis-Hansen
Journal:  Front Endocrinol (Lausanne)       Date:  2013-05-08       Impact factor: 5.555

Review 9.  On the Cutting Edge: Regulation and Therapeutic Potential of the mRNA 3' End Nuclease.

Authors:  Huiyun Liu; Claire L Moore
Journal:  Trends Biochem Sci       Date:  2021-04-30       Impact factor: 14.264

Review 10.  Molecular mechanisms of eukaryotic pre-mRNA 3' end processing regulation.

Authors:  Stefania Millevoi; Stéphan Vagner
Journal:  Nucleic Acids Res       Date:  2009-12-30       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.